Michael Kalb
Finanzdirektor/CFO bei CATALYST PHARMACEUTICALS, INC.
Aktive Positionen von Michael Kalb
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2024 | - |
Karriereverlauf von Michael Kalb
Ehemalige bekannte Positionen von Michael Kalb
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IPI LEGACY LIQUIDATION CO | Finanzdirektor/CFO | 10.05.2023 | 31.12.2023 |
CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 04.11.2022 | 01.03.2023 |
Finanzdirektor/CFO | 04.11.2022 | 01.03.2023 | |
AMARIN CORPORATION PLC | Finanzdirektor/CFO | 30.06.2016 | 20.06.2022 |
TARO PHARMACEUTICAL INDUSTRIES LTD. | Comptroller/Controller/Auditor | 15.11.2010 | 29.06.2016 |
Finanzdirektor/CFO | 22.11.2010 | 29.06.2016 | |
HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - | - |
Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Finanzdirektor/CFO | 01.06.2009 | - |
Ausbildung von Michael Kalb
State University of New York at Albany | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 2 |
Irland | 2 |
Operativ
Director of Finance/CFO | 6 |
Comptroller/Controller/Auditor | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
AMARIN CORPORATION PLC | Health Technology |
HURON CONSULTING GROUP INC. | Commercial Services |
IPI LEGACY LIQUIDATION CO | Health Technology |
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Health Technology |
CinCor Pharma, Inc.
CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Michael Kalb
- Erfahrung